Dena R Howard

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2022
Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial.

Talha Munir, Jake Emmerson, Anna Hockaday

|May 24, 2021
COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.

David Allsup, Dena Howard, Jake Emmerson

|Jan 09, 2021
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia.

Dena R Howard, Anna Hockaday, Julia M Brown

|Aug 23, 2019
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.

Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil

|Mar 25, 2017
Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.

D R Howard, T Munir, L McParland

|Dec 30, 2016
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.

Abraham M Varghese, Dena R Howard, Christopher Pocock

Pageof 1

Frequent Collaborators

2 joint publications

David Allsup

2 joint publications

Peter Hillmen

1 joint publications

A C Rawstron

1 joint publications

Talha Munir